Table C.2.

Result for the incidence of cholangiofibrosis after 36 weeks using model averaging

Model	Number of parameters	Log‐likelihood	AIC	BMD	BMDL	BMDU	Converged	Accepted AIC
Null	1	−92.10	186.20	NA	NA	NA	Yes
Full	8	−24.64	65.28	NA	NA	NA	Yes
Logistic	2	−32.17	68.34	0.35	0.27	0.44	Yes	No
Log‐logistic	3	−25.78	57.56	0.31	0.22	0.39	Yes	Yes
Log‐probit	3	−25.97	57.94	0.30	0.21	0.38	Yes	Yes
Weibull	3	−28.99	63.98	0.24	0.16	0.33	Yes	No
Gamma	3	−27.38	60.76	0.28	0.19	0.37	Yes	No
Two‐stage	3	−29.27	64.54	0.27	0.23	0.33	No	No

AIC: Akaike information criterion; BMD: benchmark dose; BMDL: benchmark dose lower confidence limit; BMDU: benchmark dose upper confidence limit.